With increased public awareness of the risks of blood transfusion and the decreased availability of blood products, the decision to transfuse a patient should be considered carefully. Most patients require a blood transfusion when haemoglobin levels fall below 8 g=dl or when there is greater than 30% loss of blood volume. However, the main indication for transfusing a patient is to increase their oxygen-carrying capacity and through invasive monitoring provide evidence of inadequate tissue oxygenation. Blood transfusions should be based on the patient’s risks of developing complications of inadequate oxygenation rather than on a single haemoglobin ‘trigger’.
Adams RC, Lundy JS.1942. Anesthesia in cases of poor surgical risk: some suggestions for decreasing the risk. Surg Gynecol Obstet74: 1011-1015.
2.
American College of Physicians. 1992. Practice strategies for elective red blood cell transfusion. Ann Int Med116: 403-406.
3.
American College of Surgeons. 1993. Advanced Trauma Life Support Course for Physicians.
4.
American Society of Anesthesiologists Task Force on Blood Component Therapy. 1996. Practice guidelines for blood component therapy. Anesthesiology84: 732-747.
5.
Bordin JO, Heddle NM, Blajchman MA.1994. Biologic effects of leucocytes present in transfused cellular blood products. Blood84: 1703-1721.
6.
Bush ORC, Hop WCJ, Hoynck van Papendrecht MAWet al.1993. Blood transfusion and prognosis in colorectal cancer surgery. New Engl J Med;328: 1372-1376.
7.
Cain SM.1965. Appearance of excess lactate in anaesthetized dogs during anemic and hypoxic hypoxia. Am J Physiol209: 604-610.
8.
Carson JLet al.1998. Perioperative transfusion and postoperative mortality. JAMA85: 199-205.
9.
Carson JL, Spence RK, Poses RMet al.1990. Elective surgery without transfusion: influence of preoperative haemoglobin level and blood loss in mortality. Am J Surg159: 320-324.
10.
Clarke R, Topley E, Flear CTGet al.1955. Assessment of blood loss in civilian trauma. Lanceti: 629-629.
11.
Consensus Conference. 1988. Perioperative red blood cell transfusion. JAMA260: 2700-2703.
12.
Crosby ET.1992. Perioperative haemotherapy. Indications for blood component thaerapy. Can J Anaesthesia39: 695-707.
Heiss MM, Mempel W, Delanoff Cet al.1994. Blood transfusion-modulated tumor recurrence: first results of a randomized study of autologous versus allogenic blood transfusion in colorectal cancer surgery. J Clin Oncol12: 1859-1867.
15.
Herbert PCet al.1999. A multicenter, randomised, controlled clinical trial of transfusion requirements in critical care. New Engl J Med340: 409-417.
16.
Hoffman JIE.1978. Determinants and prediction of transmural myocardial perfusion. Circulation58: 381-391.
17.
Houbiers JG, Brand A, van de Watering LMet al.1994. Randomised controlled trial comparing transfusion of leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer. Lancet344: 573-578.
18.
Hunt TK, Goodson WH.1989. Uncomplicated anaemia does not influence wound healing. In: Tuma RF, White JV, Mesmer K, eds. The role of hemodilution in optimal patient care. 43-50.
Irving GA.1992. Perioperative blood and blood component therapy. Can J Anaesth39: 1105-1115.
21.
Lieberman JAet al.2000. Critical oxygen delivery in conscious humans is less than 7.3 ml O2 kg min. Anaesthesiology92: 407-413.
22.
McFarland JG.1999. Perioperative blood transfusions: indications and options. Chest115: 113S-121S.
23.
Miller RD.2000. Transfusion therapy. In: Miller RD, ed. Anesthesia, New York: Churchill Livingstone, Ch 46.
24.
Milner Q, Roe P.1999. Perioperative management: anaemia. Surgery17: 102-105.
25.
Nunn JF, Freeman J.1964. Problems of oxygenation and oxygen transport during anaesthesia. Anaesthesia19: 120-120.
26.
Nacht A.1992. The use of blood products in shock. Crit Care Clin8: 255-291.
27.
Royal College of Physicians of Edinburgh. 1994. Consensus statement on red cell transfusion. Br J Anaesth73: 857-859.
28.
Nelson AHet al.1993. Relationship between postoperative anaemia and cardiac morbidity in high-risk vascular patients in the intensive care unit. Crit Care Med21: 860-866.
29.
Noble RP, Gregersen MI.1946. Blood volume in clinical shock. The extent and cause of blood volume reduction in traumatic, haemorrhagic, and burn shock. J Clin Invest25: 172-172.
30.
Paone G, Silverman NA.1997. The paradox of on-bypass trans-fusion thresholds in blood conservation. Circulation96(Suppl 19): 205-208.
31.
Schmidt PJ.1968. Transfusion in America in the eighteen and nineteenth centuries. New Engl J Med279: 1319-1319.
32.
Schou Het al.1996. Circulatory effects of hypoxia, acute normovolemic haemodilution, and their combination in anesthetized pigs. Anesthesiology84: 1443-1445.
33.
Simon TL, Alverson DC, AuBuchon Jet al.1998. Practice parameter for the use of red blood cell transfusions. Arch Pathol Lab Med122: 130-138.
34.
Spahn DRet al.1996. Haemodilution tolerance in patients with coronary artery disease who are receiving chronic b-adrenergic blocker therapy. Anaesth Analg82: 687-694.
35.
Tovey GH, Lennon GG.1962. Blood volume studies in accidental haemorrhage. J Obstet Gynae Brit Cwlth5: 749-749.
36.
Weiskopf RB, Viele MD, Fener Jet al.1998. Human cardiovascular and metabolic response to acute, severe isovolaemic anaemia. JAMA279: 217-221.
37.
van Woerkens ESCMet al.1992. Profound hemodilution: What is the critical level of hemodilution at which oxygen delivery-dependent oxygen consumption starts in an anesthetized human? Anesth Analg75: 818-821.
